- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06423092
Music Therapy Songwriting and Mental Health in Neonatel Intensive Care Unit (NICU) Parents
Short-term Effectiveness of Music Therapy Songwriting on Mental Health Outcomes of At-risk Parents in the Neonatal Intensive Care Unit: an International Multicenter Mixed-methods Study.
The mental health of parents of preterm newborns (PTNB) is negatively affected by prolonged hospitalization of the PTNB in the intensive care unit. This produces changes in the role of the parents and the bond with the newborn, leading to states of depression, anxiety, and stress. Several strategies, including music therapy, have been implemented to mitigate the negative impact on the parents' mental health.
The main objectives of the proposed trial are to determine whether Music Therapy (MT) songwriting combined with standard care (SC) during NICU stay is superior to SC alone in reducing the risk of postpartum depression in at-risk parents of preterm children at the end of treatment, and understand the lived experiences of participating parents who received music therapy for their mental health.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study employs a multicenter, mixed-method approach, with a quantitative component that will be a pragmatic parallel controlled randomized clinical trial (RCT) and a qualitative component that will include phenomenological study. The quantitative component will assess depression and anxiety, which will be evaluated with the Edinburgh Postnatal Depression Scale (EPDS) and the Generalized Anxiety Disorder Scale (GAD-7), respectively. Secondary outcomes will be resilience, coping, stress, and mental well-being. These outcomes will be measured in the first week of hospitalization (baseline measure) and then in weeks 1, 2, and 3 of the intervention. Changes in scores will be assessed to identify the effect, and mediating variables will be determined by multivariate analysis. Semi-structured interviews will be conducted on the parents' experience of music therapy songwriting for the baby.
The study will provide data on the effect of music therapy songwriting on the mental health of parents of neonates with brain injuries (PTNB) versus standard care and will document the lived experience of music therapy songs. The results may inform the standardization of this strategy in neonatal intensive care units (NICUs) to support and accompany parents and decrease the impact on their mental health.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Mark Ettenberger, PhD
- Phone Number: +57 311 284 7635
- Email: mark.ettenberger@gmx.at
Study Locations
-
-
Atlántico
-
Barranquilla, Atlántico, Colombia
- Clínica Iberoamérica en Colombia
-
Contact:
- Mark Ettenberger, PhD
- Phone Number: +57 605 3319424
- Email: mark.ettenberger@gmx.at
-
-
Cundinamarca
-
Bogotá, Cundinamarca, Colombia
- Clinica Pediatrica
-
Contact:
- Mark Ettenberger, PhD
- Phone Number: (+57) 601 745 5100
- Email: mark.ettenberger@gmx.at
-
Bogotá, Cundinamarca, Colombia
- Clínica Universitaria Colombia
-
Contact:
- Mark Ettenberger
- Phone Number: (+57) 6015948650
- Email: mark.ettenberger@gmx.at
-
Sub-Investigator:
- Marcela Beltrán, MSc
-
Principal Investigator:
- Mark Ettenberger, Phd
-
Sub-Investigator:
- Angélica Hernandez, MSc
-
Sub-Investigator:
- Ana María Diaz, MSc
-
Sub-Investigator:
- Johana Benavides, MSc
-
-
Tolima
-
Ibagué, Tolima, Colombia
- Clínica Keralty Ibagué
-
Contact:
- Mark Ettenberger, PhD
- Phone Number: +57 60 1 646 6060
- Email: mark.ettenberger@gmx.at
-
-
-
-
-
Gdańsk, Poland
- University of Gdansk
-
Principal Investigator:
- Łucja Bieleninik, PhD
-
Contact:
- Łucja Bieleninik, PhD
- Phone Number: +48 58 523 30 00
- Email: lucja.bieleninik@ug.edu.pl
-
Sub-Investigator:
- Ilona Poćwierz-Marciniak, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- The study population consisted of parents/caregivers of newborns hospitalized in neonatal intensive care units (NICUs) with gestational ages of ≤32 weeks and expected hospitalizations of at least three weeks. In the case of a twin pregnancy, the firstborn infant was randomly assigned to one of the intervention groups, while both infants received the same treatment according to the outcome of randomization.
- Mother a total score of ≥10 and/or father a total score of ≥7 on the EPDS (Edinburgh Postnatal Depression Scale)
- Mother and/or father a total score of ≥8 on the GAD-7 (Generalized Anxiety Disorder Scale)
Exclusion Criteria:
- Parents/caregivers with known auditory problems that prevent participation in MT.
Moreover parents/caregivers with a documented mental illness or cognitive impairment that prevents them from being able to complete the study intervention or outcome assessments.
- Parents/caregivers of premature infants in palliative or end-of-life care, infants with known hearing impairment, or infants in the custody of social services.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Music therapy songwriting + standard care
The music therapy songwriting is a method frequently employed in music therapy sessions.
This method involves the collaborative creation of lyrics and/or music with the participants.
The intervention will consist of nine sessions, each of which will last approximately 30 to 45 minutes.
Three sessions will be conducted per week until a minimum of six and a maximum of nine sessions are achieved.
|
Session 1: The goal of the first music therapy session is to know the parents musically and to provide information about song creation. This is achieved by exploring their favorite songs. Options for creating a song (original song or song parody) are presented and possibilities for creating lyrics are discussed. Sessions 2-7: The structure of the song will be created and discussed with the parents. Parents will also be invited to include written messages from other family members in the lyrics if they wish. In each session, the developing welcome song is sung together with the parents, accompanied by the music therapist, who provides vocal or instrumental support. The final sessions (Sessions 8-9) are dedicated to singing the final version of the song with the parents and their infant. Should the parents desire, a final recording of the song will also be made and the digital songbook will be created. |
|
No Intervention: Standard care
Standard care is the usual care provided to parents of newborns hospitalized in a neonatal intensive care unit (NICU).
This care includes providing information about the baby's health status and recommendations during contact with the baby.
Additionally, when a health professional identifies symptoms of mental health disturbance in the parents, they are referred to a mental health professional for appropriate management.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postpartum depression
Time Frame: It will be measured during the first week of hospitalization (baseline measurement) and at weeks 1, 2, and 3 of the intervention.
|
Postpartum depression will be assessed with the Edinburgh Postnatal Depression Scale (EPDS).
This scale has values between 0 to 30 points.
Higher scores mean a worse outcome.
|
It will be measured during the first week of hospitalization (baseline measurement) and at weeks 1, 2, and 3 of the intervention.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety
Time Frame: It will be measured during the first week of hospitalization (baseline measurement) and at weeks 2 and 3 of the intervention.
|
Anxiety will be assessed with the Generalized Anxiety Disorder Scale (GAD-7).
Minimum and maximum possible scores of 0 and 21 respectively.
Higher scores mean a worse outcome.
|
It will be measured during the first week of hospitalization (baseline measurement) and at weeks 2 and 3 of the intervention.
|
|
Well-being
Time Frame: It will be measured during the first week of hospitalization (baseline measurement) and at weeks 2 and 3 of the intervention.
|
The Warwick Edinburgh Mental Well-Being Scale (WEMWBS) will be employed to assess well-being.
Minimum and maximum possible scores of 14 and 70 respectively.
Higher scores mean a better wellbeing.
|
It will be measured during the first week of hospitalization (baseline measurement) and at weeks 2 and 3 of the intervention.
|
|
Resilience
Time Frame: It will be measured during the first week of hospitalization (baseline measurement) and at week 3 of the intervention.
|
Resilience will be assessed with the Brief Resilience Scale (BRS).
Participants respond on a 5-point Likert scale, ranging from 1 (Strongly Disagree) to 5 (Strongly Agree) and giving a range from 6-30.
Higher scores mean a better resilience.
|
It will be measured during the first week of hospitalization (baseline measurement) and at week 3 of the intervention.
|
|
Stress
Time Frame: It will be measured during the first week of hospitalization (baseline measurement) and at week 3 of the intervention.
|
Stress will be assessed with the 10-item Perceived Stress Scale (PSS-10).
Answers are then scored on Likert scale from 0 "Never" to 4 "Very often".
Higher scores indicate higher levels of perceived stress.
|
It will be measured during the first week of hospitalization (baseline measurement) and at week 3 of the intervention.
|
|
Coping
Time Frame: It will be measured during the first week of hospitalization (baseline measurement) and at week 3 of the intervention.
|
Stress response will be assessed with the Brief COPE Inventory (Brief-COPE).
Scores are presented on Likert scale from 1 " I haven't been doing this at all" to 4 "I've been doing this a lot".
|
It will be measured during the first week of hospitalization (baseline measurement) and at week 3 of the intervention.
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 166-23 UNV
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Health Impairment
-
Norwegian University of Science and TechnologyRecruitingMental Health ImpairmentNorway
-
Stony Brook UniversityUnknownMental Health ImpairmentUnited States
-
University of BergenHaukeland University Hospital; Wisconsin Department of Health and Family Services and other collaboratorsCompleted
-
Boston CollegeUniversity of Georgia; Caritas Freetown; German Society for International CooperationCompletedMental Health Disorder | Mental Health Impairment | Psychosocial Impairment | Emotional DysfunctionSierra Leone
-
University of RoehamptonMIND Tower HamletsTerminatedMental Health ImpairmentUnited Kingdom
-
Stony Brook UniversityCompletedMental Health ImpairmentUnited States
-
McMaster UniversityHamilton Health Sciences Corporation; Ontario Mental Health Foundation; St. Joseph...CompletedMental Health ImpairmentCanada
-
University of WarwickKing's College London; KU Leuven; University Hospital, Montpellier; Erasmus Medical... and other collaboratorsUnknownMental Health Disorder | Mental Health ImpairmentIreland, United Kingdom, Netherlands, Germany, Belgium, Croatia, France, Italy
-
Haukeland University HospitalUniversity of BergenEnrolling by invitationChild, Only | Mental Health Impairment | Health Care Utilization | Multi-morbidityNorway
-
Boston CollegeUniversity of Georgia; Innovations for Poverty Action; Caritas Freetown; German...CompletedMental Health Disorder | Mental Health Impairment | Psychosocial ProblemSierra Leone
Clinical Trials on Music therapy songwriting
-
Mayo ClinicRecruitingSickle Cell DiseaseUnited States
-
Vanderbilt University Medical CenterNational Endowment for the Arts, United StatesCompletedStress | Intellectual Disability | Autism Spectrum Disorder | Parents | Developmental DisabilityUnited States
-
The University of Hong KongRecruitingStress | Anxiety | Depressive SymptomsHong Kong
-
Vanderbilt UniversityCompleted
-
Case Comprehensive Cancer CenterCompletedMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin LymphomaUnited States
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences InstituteCompletedAutonomic Nervous System Imbalance | Hypothalamic Pituitary Adrenal Axis SuppressionUnited States
-
University of PennsylvaniaConestoga High SchoolCompletedStress | Cognitive Impairment | DementiaUnited States
-
Wayne State UniversityCompletedNeurological DisordersUnited States
-
Icahn School of Medicine at Mount SinaiCompletedSARS-CoV 2 | Dyspnea | Post Covid-19 RespiratoryUnited States
-
Icahn School of Medicine at Mount SinaiCompleted